| 1 |
Shimshak S, Dai C, Comfere N, Sokumbi O. Characterization of primary cutaneous T-cell lymphoma following solid organ transplantation. Int J Dermatol 2023;62:494-500. [PMID: 35687656 DOI: 10.1111/ijd.16300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Rassek K, Iżykowska K, Żurawek M, Nowicka K, Joks M, Olek-Hrab K, Olszewska B, Sokołowska-Wojdyło M, Biernat W, Nowicki RJ, Przybylski GK. TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sézary Syndrome from Mycosis Fungoides and Benign Erythroderma. J Invest Dermatol 2023;143:344-347.e3. [PMID: 36087622 DOI: 10.1016/j.jid.2022.08.046] [Reference Citation Analysis]
|
| 3 |
Gluud M, Pallesen EMH, Buus TB, Gjerdrum LMR, Lindahl LM, Kamstrup MR, Bzorek M, Danielsen M, Bech R, Monteiro MN, Blümel E, Willerslev-Olsen A, Lykkebo-Valløe A, Vadivel CK, Krejsgaard T, Bonefeld CM, Geisler C, Becker JC, Koralov SB, Iversen L, Litman T, Woetmann A, Ødum N. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma. Blood 2023;141:180-93. [PMID: 36122387 DOI: 10.1182/blood.2022016690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Shimshak S, Sokumbi O, Isaq N, Goyal A, Comfere N. A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma. Dermatologic Clinics 2023;41:209-229. [DOI: 10.1016/j.det.2022.07.019] [Reference Citation Analysis]
|
| 5 |
Pires AM, Borges F, Dias AG, Joana L, Matos M, Gonçalves J. Paraffin gauze bolus as tissue compensator in photon irradiation for mycosis fungoides – regarding a case study. J Radiother Pract 2023;22:e82. [DOI: 10.1017/s1460396923000109] [Reference Citation Analysis]
|
| 6 |
Hughes MS, Sterling CH, Varadhan R, Ambinder RF, Jones RJ, Sweren RJ, Rozati S, Bolaños-Meade J, Luznik L, Imus PH, Ali SA, Borrello IM, Huff CA, Jain T, Ambinder A, DeZern AE, Gocke CB, Gladstone DE, Swinnen LJ, Wagner-Johnston ND, Fuchs EJ. Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study. Leuk Lymphoma 2022;63:2987-91. [PMID: 35915978 DOI: 10.1080/10428194.2022.2105330] [Reference Citation Analysis]
|
| 7 |
Geng X, Wang C, Gao X, Chowdhury P, Weiss J, Villegas JA, Saed B, Perera T, Hu Y, Reneau J, Sverdlov M, Wolfe A, Brown N, Harms P, Bailey NG, Inamdar K, Hristov AC, Tejasvi T, Montes J, Barrionuevo C, Taxa L, Casavilca S, de Pádua Covas Lage JLA, Culler HF, Pereira J, Runge JS, Qin T, Tsoi LC, Hong HS, Zhang L, Lyssiotis CA, Ohe R, Toubai T, Zevallos-Morales A, Murga-Zamalloa C, Wilcox RA. GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms. Blood Cancer J 2022;12:149. [PMID: 36329027 DOI: 10.1038/s41408-022-00745-y] [Reference Citation Analysis]
|
| 8 |
Fki A, Kotti N, Dhouib F, Kammoun N, Frikha M, Jmal Hammami K, Masmoudi M, Turki H, Hajjaji M. Les facteurs professionnels associés au mycosis fongoïde. Archives des Maladies Professionnelles et de l'Environnement 2022. [DOI: 10.1016/j.admp.2022.10.007] [Reference Citation Analysis]
|
| 9 |
Lanier OL, Pérez-herrero E, Andrea APD, Bahrami K, Lee E, Ward DM, Ayala-suárez N, Rodríguez-méndez SM, Peppas NA. Immunotherapy approaches for hematological cancers. iScience 2022;25:105326. [DOI: 10.1016/j.isci.2022.105326] [Reference Citation Analysis]
|
| 10 |
Patil K, Kuttikrishnan S, Khan AQ, Ahmad F, Alam M, Buddenkotte J, Ahmad A, Steinhoff M, Uddin S. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways. Semin Cancer Biol 2022;86:382-99. [PMID: 34906723 DOI: 10.1016/j.semcancer.2021.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Rodrigues-Fernandes CI, Vargas PA, de Aquino IG, Lopes MA, Santos-Silva AR. Sézary syndrome: Report of a rare case with perioral manifestation and review of the literature. Oral Oncol 2022;134:106134. [PMID: 36183500 DOI: 10.1016/j.oraloncology.2022.106134] [Reference Citation Analysis]
|
| 12 |
Olisova OY, Demkin VV, Chernova NG, Amshinskaya JR, Kazakov AA. MicroRNA as a diagnostic marker in cutaneous T-cell lymphomas. Russian Journal of Skin and Venereal Diseases 2022;25:5-16. [DOI: 10.17816/dv106327] [Reference Citation Analysis]
|
| 13 |
Wang HQ, Ji C, Bao CB, Gong T, Elston DM. Facial milia-like eruption in a patient with alopecia. JAAD Case Rep 2022;25:111-3. [PMID: 35898669 DOI: 10.1016/j.jdcr.2022.02.044] [Reference Citation Analysis]
|
| 14 |
Parsons MW, Wada DA, Halwani AS, Tao R, Gaffney DK. Improved overall survival over time in advanced stage mycosis fungoides: a cross-sectional study. Leukemia & Lymphoma 2022. [DOI: 10.1080/10428194.2022.2081322] [Reference Citation Analysis]
|
| 15 |
Filonenko EV, Ivanova-radkevich VI. Photodynamic therapy in the treatment of patients with mycosis fungoides. Biomedical photonics 2022;11:27-36. [DOI: 10.24931/2413-9432-2022-11-1-27-36] [Reference Citation Analysis]
|
| 16 |
Filonenko EV, Ivanova-radkevich VI. Photodynamic therapy in the treatment of patients with mycosis fungoides. Biomedical photonics 2022;11:29-38. [DOI: 10.24931/2413-9432-2022-11-1-27-37] [Reference Citation Analysis]
|
| 17 |
Chen C, Liu Z, Liu J, Zhang W, Zhou D, Zhang Y. Case Report: Outcome and Adverse Events of Anti-PD-1 Antibody Plus Chidamide for Relapsed/Refractory Sézary Syndrome: Case Series and A Literature Review. Front Oncol 2022;12:842123. [PMID: 35387123 DOI: 10.3389/fonc.2022.842123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Chebly A, Ropio J, Baldasseroni L, Prochazkova-carlotti M, Idrissi Y, Ferrer J, Farra C, Beylot-barry M, Merlio J, Chevret E. Telomeric Repeat-Containing RNA (TERRA): A Review of the Literature and First Assessment in Cutaneous T-Cell Lymphomas. Genes 2022;13:539. [DOI: 10.3390/genes13030539] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 19 |
Kita K, Nakatani-Kusakabe M, Nagai M, Yamanishi K, Natsuaki M, Imai Y, Kanazawa N. Single-cell RNA sequencing of mycosis fungoides reveals a cluster of actively proliferating lymphocytes. Australas J Dermatol 2022. [PMID: 35254671 DOI: 10.1111/ajd.13794] [Reference Citation Analysis]
|
| 20 |
Albanese F, Abramo F, Marino M, Massaro M, Marconato L, Minoli L, Martini V, Aresu L. Feline and Canine Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease? Vet Sci 2022;9:26. [PMID: 35051110 DOI: 10.3390/vetsci9010026] [Reference Citation Analysis]
|
| 21 |
Wen P, Xie Y, Wang L. The Role of microRNA in Pathogenesis, Diagnosis, Different Variants, Treatment and Prognosis of Mycosis Fungoides. Front Oncol 2021;11:752817. [PMID: 34966672 DOI: 10.3389/fonc.2021.752817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Gan L, Shi H, Zhang Y, Sun J, Chen H. Proteomic Screening and Verification of Biomarkers in Different Stages of Mycosis Fungoides: A pilot Study. Front Cell Dev Biol 2021;9:747017. [PMID: 34966737 DOI: 10.3389/fcell.2021.747017] [Reference Citation Analysis]
|
| 23 |
Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides und Sézary-Syndrom. J Dtsch Dermatol Ges 2021;19:1307-35. [PMID: 34541808 DOI: 10.1111/ddg.14610_g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Jonak C, Tittes J, Brunner PM, Guenova E. Mycosis fungoides and Sézary syndrome. J Dtsch Dermatol Ges 2021;19:1307-34. [PMID: 34541796 DOI: 10.1111/ddg.14610] [Reference Citation Analysis]
|
| 25 |
Patel RP, Thomas JR, Curt KM, Fitzsimmons CM, Batista PJ, Bates SE, Gottesman MM, Robey RW. Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma. Invest Ophthalmol Vis Sci 2021;62:16. [PMID: 34533562 DOI: 10.1167/iovs.62.12.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
S Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis. Am J Hematol 2021;96:E350-3. [PMID: 34096089 DOI: 10.1002/ajh.26266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Polívka J. Mogamulizumab: new treatment option for advanced stages cutaneous T-cell lymphomas -mycosis fungoides and Sezary syndrome. Onkologie 2021;15:187-193. [DOI: 10.36290/xon.2021.037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 28 |
Dummer R, Vermeer MH, Scarisbrick JJ, Kim YH, Stonesifer C, Tensen CP, Geskin LJ, Quaglino P, Ramelyte E. Cutaneous T cell lymphoma. Nat Rev Dis Primers 2021;7:61. [PMID: 34446710 DOI: 10.1038/s41572-021-00296-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 29 |
Barron CR, Smoller BR. Evaluation of Melanocyte Loss in Mycosis Fungoides Using SOX10 Immunohistochemistry. Dermatopathology (Basel) 2021;8:277-84. [PMID: 34287276 DOI: 10.3390/dermatopathology8030034] [Reference Citation Analysis]
|
| 30 |
Zhang P, Zhang M. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma. Front Oncol 2021;11:663961. [PMID: 34249700 DOI: 10.3389/fonc.2021.663961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 31 |
Hernández-Coronado M, Gómez-Almaguer D, Jaime-Pérez JC. Haploidentical hematopoietic cell transplantation for mycosis fungoides/ Sezary syndrome using reduced intensity conditioning after brentuximab therapy discontinuation: advantages of an outpatient program in the times of COVID-19. Hematol Transfus Cell Ther 2021:S2531-1379(21)00088-2. [PMID: 34253503 DOI: 10.1016/j.htct.2021.05.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 32 |
Catherine J, Roufosse F. What does elevated TARC/CCL17 expression tell us about eosinophilic disorders? Semin Immunopathol 2021;43:439-58. [PMID: 34009399 DOI: 10.1007/s00281-021-00857-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 33 |
Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schiöth HB. Recent developments of HDAC inhibitors: Emerging indications and novel molecules. Br J Clin Pharmacol 2021. [PMID: 33971031 DOI: 10.1111/bcp.14889] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 34 |
Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS. Stellenwert diagnostischer Verfahren und Risiko von Zweittumoren bei primär kutanen Lymphomen. J Dtsch Dermatol Ges 2021;19:373-82. [PMID: 33709586 DOI: 10.1111/ddg.14400_g] [Reference Citation Analysis]
|
| 35 |
Scheu A, Schnabl SM, Steiner DP, Fend F, Berneburg M, Yazdi AS. Importance of diagnostics and risk of secondary malignancies in primary cutaneous lymphomas. J Dtsch Dermatol Ges 2021;19:373-81. [PMID: 33576187 DOI: 10.1111/ddg.14400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Reneau JC, Wilcox RA. Novel therapies targeting cutaneous T cell lymphomas and their microenvironment. Semin Hematol 2021;58:103-13. [PMID: 33906720 DOI: 10.1053/j.seminhematol.2021.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Bedier H, Lin J, Julien LA, Routy JP. Concurrent development of HIV-negative Kaposi's sarcoma and mycosis fungoides in an elderly Inuit from Canada. BMJ Case Rep 2021;14:e238644. [PMID: 33509877 DOI: 10.1136/bcr-2020-238644] [Reference Citation Analysis]
|
| 38 |
Vadivel CK, Gluud M, Torres-Rusillo S, Boding L, Willerslev-Olsen A, Buus TB, Nielsen TK, Persson JL, Bonefeld CM, Geisler C, Krejsgaard T, Fuglsang AT, Odum N, Woetmann A. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL). Cancers (Basel) 2021;13:280. [PMID: 33466582 DOI: 10.3390/cancers13020280] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 39 |
Wilhelm R, Eckes T, Imre G, Kippenberger S, Meissner M, Thomas D, Trautmann S, Merlio JP, Chevret E, Kaufmann R, Pfeilschifter J, Koch A, Jäger M. C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma. Cancers (Basel) 2021;13:E270. [PMID: 33450826 DOI: 10.3390/cancers13020270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 40 |
Zinzani PL, Quaglino P, Violetti SA, Cantonetti M, Goteri G, Onida F, Paulli M, Rupoli S, Barosi G, Pimpinelli N. Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma. Hematol Oncol 2021;39:275-83. [PMID: 33855728 DOI: 10.1002/hon.2832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Reyes Barron C, Smoller BR. Skin Tumors. Practical Oncologic Molecular Pathology 2021. [DOI: 10.1007/978-3-030-73227-1_9] [Reference Citation Analysis]
|
| 42 |
Stadler R, Scarisbrick JJ. Maintenance therapy in patients with mycosis fungoides or Sézary syndrome: A neglected topic. Eur J Cancer 2021;142:38-47. [PMID: 33217680 DOI: 10.1016/j.ejca.2020.10.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 43 |
Neema S, Das A. Rare etiology of generalized pruritus: Two cases of Sezary syndrome with review of therapy. Dermatol Ther 2020;33:e14300. [PMID: 32916027 DOI: 10.1111/dth.14300] [Reference Citation Analysis]
|
| 44 |
Navarro-almenzar B, Belmonte MM, Espuch JG. Linfomas. Medicine - Programa de Formación Médica Continuada Acreditado 2020;13:1125-1132. [DOI: 10.1016/j.med.2020.11.002] [Reference Citation Analysis]
|
| 45 |
Scarisbrick JJ, Bagot M, Ortiz-Romero PL. The changing therapeutic landscape, burden of disease, and unmet needs in patients with cutaneous T-cell lymphoma. Br J Haematol 2021;192:683-96. [PMID: 33095448 DOI: 10.1111/bjh.17117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 46 |
Brouwer IJ, Out-Luiting JJ, Vermeer MH, Tensen CP. Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells. Biochem Biophys Rep 2020;24:100832. [PMID: 33102814 DOI: 10.1016/j.bbrep.2020.100832] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 47 |
Stolearenco V, Namini MRJ, Hasselager SS, Gluud M, Buus TB, Willerslev-Olsen A, Ødum N, Krejsgaard T. Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma. Front Cell Dev Biol 2020;8:851. [PMID: 33015047 DOI: 10.3389/fcell.2020.00851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 48 |
Szczepiorkowski ZM. Indications for therapeutic apheresis in hematological disorders. Semin Hematol 2020;57:57-64. [PMID: 32892844 DOI: 10.1053/j.seminhematol.2020.07.008] [Reference Citation Analysis]
|
| 49 |
Gluud M, Willerslev-Olsen A, Gjerdrum LMR, Lindahl LM, Buus TB, Andersen MH, Bonefeld CM, Krejsgaard T, Litvinov IV, Iversen L, Becker JC, Persson JL, Koralov SB, Litman T, Geisler C, Woetmann A, Odum N. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas. Cancers (Basel) 2020;12:E1229. [PMID: 32414221 DOI: 10.3390/cancers12051229] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 50 |
Li H, Wang C, Ma P, Zhang M, Yang H, Yuan S, Wei J, Tao L, Qian K, Xu M, Li L. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway. J Dermatol Sci 2020;97:208-15. [PMID: 32165081 DOI: 10.1016/j.jdermsci.2020.01.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
